Systematic review and meta-analysis of randomised, phase II/III trials adding bevacizumab to platinum-based chemotherapy as first-line treatment in patients with advanced non-small-cell lung cancer

By  

Annals of Oncology, Vol. 24, Iss. 4, 2013-04 ,pp. : 1133-1133

Oxford University Press

Access to resources Recommend Favorite

The predictive value of BRCA1 and RAP80 mRNA expression in advanced non-small-cell lung cancer patients treated with platinum-based chemotherapy

By Bonanno L.   Costa C.   Majem M.   Favaretto A.   Rugge M.   Rosell R.  

Annals of Oncology, Vol. 24, Iss. 4, 2013-04 ,pp. : 1130-1132

Oxford University Press

Access to resources Recommend Favorite

Predictive value of ERCC1 and RRM1 gene single-nucleotide polymorphisms for first-line platinum- and gemcitabine-based chemotherapy in non-small cell lung cancer patients

By                        

Oncology Reports, Vol. 30, Iss. 5, 2013-01 ,pp. : 2385-2398

Spandidos Publications

Access to resources Recommend Favorite

Predictive effect of XRCC3 Thr241Met polymorphism on platinum-based chemotherapy in lung cancer patients: meta-analysis

By Zhang Wei   Yan Bo   Jiang Liyan  

Tumor Biology, Vol. 34, Iss. 6, 2013-12 ,pp. : 3989-3993

Springer Publishing Company

Access to resources Recommend Favorite

Quality of life in advanced non-small cell lung cancer patients receiving palliative chemotherapy: A meta-analysis of randomized controlled trials

By      

Experimental and Therapeutic Medicine, Vol. 3, Iss. 1, 2012-01 ,pp. : 134-140

Spandidos Publications

Access to resources Recommend Favorite